STATEMENT OF NEED/TARGET AUDIENCE

Medical oncology, particularly breast cancer, is one of the most rapidly advancing and developing fields of medicine. The constant emergence of new systemic agents, new indications for existing systemic agents, novel therapies, clinical trials and research findings demands that oncology nurses remain dedicated to continuing education in order to offer their patients the best care possible. This program provides registered nurses access to the most up-to-date research developments in breast cancer and the opinions of oncology nurses and clinical investigators with experience and expertise in the field. This information can be effectively translated into everyday patient management decisions.

PURPOSE STATEMENT

To present the most current research developments in breast cancer and to provide the perspectives of medical oncologists, oncology nurses and patients on the diagnosis and treatment of breast cancer.

EDUCATIONAL OBJECTIVES FOR THIS ISSUE OF BREAST CANCER UPDATE  FOR NURSES

• Discuss the clinical implications of emerging clinical trial data in breast cancer treatment and how to incorporate these data into management strategies in the adjuvant, neoadjuvant and metastatic settings.
• Discuss the selection and sequencing of endocrine therapy in the adjuvant and metastatic settings.
• Describe the risks and benefits of chemotherapeutic agents and regimens in the adjuvant and metastatic settings.
• Describe the computerized risk models and genetic markers to determine prognostic information on the quantitative risk of breast cancer relapse.
• Explain the risks and benefits of incorporating biologic agents in the adjuvant and metastatic settings.
• Discuss psychosocial and emotional needs of caregivers, patients and their loved ones associated with the diagnosis and treatment of breast cancer.

ACCREDITATION STATEMENTS

This educational activity for 2.7 contact hours is provided by Research To Practice during the period of July 2007 through July 2008.

Research To Practice is an approved provider of continuing nursing education by the New Jersey State Nurses Association, Provider Number P215-01/07-10. NJSNA is accredited by the ANCC Commission on Accreditation. Provider Approval is valid through January 31, 2010.

HOW TO USE THIS CNE ACTIVITY

This is an audio CNE activity. This website contains a continuing nursing education Post-test and Evaluation Form, and links to relevant full-text articles and abstracts. There are no fees for participating and receiving CNE credit for this activity. To receive credit during the period of July 2007 through July 2008, participants should read the learning objectives and faculty disclosures, listen to the audio program and complete the Post-test and Evaluation Form. Certificates may be printed online or mailed to participants.

This program is supported by education grants from Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Genomic Health Inc and Sanofi-Aventis.

Table of Contents

Top of Page